|
GB581334A
(en)
|
1943-09-29 |
1946-10-09 |
Francis Henry Swinden Curd |
New pyrimidine compounds
|
|
JPS4921149B1
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
|
1970-12-28 |
1974-05-30 |
|
|
|
JPS4921148B1
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
|
1970-12-28 |
1974-05-30 |
|
|
|
AT340933B
(de)
|
1973-08-20 |
1978-01-10 |
Thomae Gmbh Dr K |
Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
|
|
DE2341925A1
(de)
|
1973-08-20 |
1975-03-06 |
Thomae Gmbh Dr K |
Neue pyrimidinderivate und verfahren zu ihrer herstellung
|
|
US4994386A
(en)
|
1987-07-13 |
1991-02-19 |
Pharmacia Diagnostics, Inc. |
Production of HBLV virus in the HSB-2 cell line
|
|
US4929726A
(en)
|
1988-02-09 |
1990-05-29 |
Georgia State University Foundation, Inc. |
Novel diazines and their method of preparation
|
|
EP0330263A1
(en)
|
1988-02-25 |
1989-08-30 |
Merck & Co. Inc. |
Piperazinylalkylpyrimidines as hypoglycemic agents
|
|
GB9012311D0
(en)
|
1990-06-01 |
1990-07-18 |
Wellcome Found |
Pharmacologically active cns compounds
|
|
ATE139117T1
(de)
|
1990-07-03 |
1996-06-15 |
Mitsui Petrochemical Ind |
Pyrimidin-verbindung und ihr pharmazeutisch annehmbares salz
|
|
JP3145410B2
(ja)
|
1995-04-13 |
2001-03-12 |
大鵬薬品工業株式会社 |
新規な４，６−ジアリールピリミジン誘導体及びその塩
|
|
JP3734907B2
(ja)
|
1996-12-19 |
2006-01-11 |
富士写真フイルム株式会社 |
現像処理方法
|
|
JP4276376B2
(ja)
|
1997-07-24 |
2009-06-10 |
全薬工業株式会社 |
複素環式化合物及びそれを有効成分とする抗腫瘍剤
|
|
JPH11158073A
(ja)
|
1997-09-26 |
1999-06-15 |
Takeda Chem Ind Ltd |
アデノシンａ３拮抗剤
|
|
US6440965B1
(en)
|
1997-10-15 |
2002-08-27 |
Krenitsky Pharmaceuticals, Inc. |
Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
|
|
US6150362A
(en)
|
1997-12-12 |
2000-11-21 |
Henkin; Jack |
Triazine angiogenesis inhibitors
|
|
ATE236136T1
(de)
|
1998-01-16 |
2003-04-15 |
Hoffmann La Roche |
Benzosulfonderivate
|
|
US7045519B2
(en)
|
1998-06-19 |
2006-05-16 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
|
US6489344B1
(en)
|
1998-06-19 |
2002-12-03 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
|
US6495558B1
(en)
|
1999-01-22 |
2002-12-17 |
Amgen Inc. |
Kinase inhibitors
|
|
CA2359680A1
(en)
|
1999-01-22 |
2000-07-27 |
David M. Armistead |
Kinase inhibitors
|
|
EP1194152A4
(en)
|
1999-06-30 |
2002-11-06 |
Merck & Co Inc |
SIN KINASE INHIBITOR COMPOUNDS
|
|
WO2001000213A1
(en)
|
1999-06-30 |
2001-01-04 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
|
WO2001000207A1
(en)
|
1999-06-30 |
2001-01-04 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
|
CA2379064A1
(en)
|
1999-07-15 |
2001-01-25 |
Pharmacopeia, Inc. |
Bradykinin b1 receptor antagonists
|
|
JP2001089452A
(ja)
|
1999-09-22 |
2001-04-03 |
Sankyo Co Ltd |
ピリミジン誘導体
|
|
KR20030024659A
(ko)
|
2000-02-17 |
2003-03-26 |
암겐 인코포레이티드 |
키나제 억제제
|
|
NZ521068A
(en)
|
2000-03-29 |
2005-04-29 |
Cyclacel Ltd |
2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
|
|
DE60144322D1
(de)
|
2000-04-27 |
2011-05-12 |
Astellas Pharma Inc |
Kondensierte heteroarylderivate
|
|
NZ522217A
(en)
|
2000-04-28 |
2004-04-30 |
Tanabe Seiyaku Co |
Cyclic compounds
|
|
CA2409762A1
(en)
|
2000-06-23 |
2002-01-03 |
Donald J.P. Pinto |
Heteroaryl-phenyl substituted factor xa inhibitors
|
|
AU2001295026B2
(en)
|
2000-09-06 |
2008-04-03 |
Novartis Vaccines And Diagnostics, Inc. |
Inhibitors of glycogen synthase kinase 3
|
|
KR20030032035A
(ko)
|
2000-09-15 |
2003-04-23 |
버텍스 파마슈티칼스 인코포레이티드 |
단백질 키나제 억제제로서 유용한 피라졸 화합물
|
|
SE0004053D0
(sv)
|
2000-11-06 |
2000-11-06 |
Astrazeneca Ab |
N-type calcium channel antagonists for the treatment of pain
|
|
HUP0400908A3
(en)
|
2000-12-21 |
2010-03-29 |
Vertex Pharma |
Pyrazole compounds useful as protein kinase inhibitors, their use and pharmaceutical compositions containing them
|
|
WO2002062766A2
(en)
|
2001-02-07 |
2002-08-15 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
US20030130264A1
(en)
|
2001-02-16 |
2003-07-10 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
|
JP2004531571A
(ja)
|
2001-05-25 |
2004-10-14 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
サイトカイン生産のインヒビターとしてのカルバメート及びオキサミド化合物
|
|
JP2005500294A
(ja)
|
2001-06-19 |
2005-01-06 |
ブリストル−マイヤーズ スクイブ カンパニー |
ホスホジエステラーゼ７に対するピリミジン阻害剤
|
|
US6603000B2
(en)
|
2001-07-11 |
2003-08-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis for heteroarylamine compounds
|
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
DE60327999D1
(de)
|
2002-03-15 |
2009-07-30 |
Vertex Pharma |
Azolylaminoazine als inhibitoren von proteinkinasen
|
|
ES2289279T3
(es)
|
2002-03-15 |
2008-02-01 |
Vertex Pharmaceuticals Incorporated |
Composiciones utiles como inhibidores de proteinquinasas.
|
|
ATE468336T1
(de)
|
2002-03-15 |
2010-06-15 |
Vertex Pharma |
Azolylaminoazine als proteinkinasehemmer
|
|
US7091343B2
(en)
|
2002-03-15 |
2006-08-15 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
|
AU2003245669A1
(en)
|
2002-06-21 |
2004-01-06 |
Cellular Genomics, Inc. |
Certain aromatic monocycles as kinase modulators
|
|
CA2499497A1
(en)
|
2002-09-27 |
2004-04-08 |
Merck & Co., Inc. |
Substituted pyrimidines
|
|
AU2003288925A1
(en)
|
2002-10-08 |
2004-05-04 |
Massachusetts Institute Of Technology |
Compounds for modulation of cholesterol transport
|
|
US7223870B2
(en)
|
2002-11-01 |
2007-05-29 |
Pfizer Inc. |
Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
|
|
EP2316831B1
(en)
|
2002-11-21 |
2013-03-06 |
Novartis AG |
2-(morpholin-4-yl)pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
|
|
CA2514733A1
(en)
*
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
|
JP2006521357A
(ja)
|
2003-03-24 |
2006-09-21 |
メルク エンド カムパニー インコーポレーテッド |
ナトリウムチャンネル遮断薬としてのビアリール置換６員複素環化合物
|
|
US20050014753A1
(en)
|
2003-04-04 |
2005-01-20 |
Irm Llc |
Novel compounds and compositions as protein kinase inhibitors
|
|
EP1610774A4
(en)
|
2003-04-09 |
2008-07-16 |
Exelixis Inc |
TIE-2 MODULATORS AND METHODS OF USE
|
|
WO2005009977A1
(en)
|
2003-07-15 |
2005-02-03 |
Neurogen Corporation |
Substituted pyrimidin-4-ylamina analogues as vanilloid receptor ligands
|
|
US7566712B2
(en)
|
2003-07-16 |
2009-07-28 |
Neurogen Corporation |
Biaryl piperazinyl-pyridine analogues
|
|
PE20050952A1
(es)
|
2003-09-24 |
2005-12-19 |
Novartis Ag |
Derivados de isoquinolina como inhibidores de b-raf
|
|
DE602005024382D1
(de)
|
2004-04-13 |
2010-12-09 |
Astellas Pharma Inc |
Polycyclische pyrimidine als kaliumionenkanal-modulatoren
|
|
GB0415364D0
(en)
|
2004-07-09 |
2004-08-11 |
Astrazeneca Ab |
Pyrimidine derivatives
|
|
GB0415365D0
(en)
|
2004-07-09 |
2004-08-11 |
Astrazeneca Ab |
Pyrimidine derivatives
|
|
MY145822A
(en)
|
2004-08-13 |
2012-04-30 |
Neurogen Corp |
Substituted biaryl piperazinyl-pyridine analogues
|
|
JP2008521900A
(ja)
*
|
2004-11-30 |
2008-06-26 |
アムジエン・インコーポレーテツド |
キノリン及びキナゾリン類似体並びにがん治療のための医薬としてのその使用
|
|
US20080045525A1
(en)
|
2004-12-13 |
2008-02-21 |
Rajagopal Bakthavatchalam |
Piperazinyl-Pyridine Analogues
|
|
AU2005322328A1
(en)
|
2004-12-13 |
2006-07-06 |
Neurogen Corporation |
Substituted biaryl analogues
|
|
JP5124285B2
(ja)
|
2004-12-28 |
2013-01-23 |
キネックス ファーマシューティカルズ， エルエルシー |
細胞増殖性障害を処置する組成物および方法
|
|
CN101107245A
(zh)
|
2005-01-19 |
2008-01-16 |
神经能质公司 |
经杂芳基取代的哌嗪-吡啶类似物
|
|
CA2599320A1
(en)
|
2005-02-25 |
2006-08-31 |
Kudos Pharmaceuticals Limited |
Hydrazinomethyl, hydr zonomethyl and 5-membered heterocylic compounds which act as mtor inhibitors and their use as anti cancer agents
|
|
JP2008536950A
(ja)
|
2005-04-18 |
2008-09-11 |
ニューロジェン・コーポレーション |
置換ヘテロアリールのｃｂ１拮抗薬
|
|
GB2431156A
(en)
|
2005-10-11 |
2007-04-18 |
Piramed Ltd |
1-cyclyl-3-substituted- -benzenes and -azines as inhibitors of phosphatidylinositol 3-kinase
|
|
WO2007080382A1
(en)
|
2006-01-11 |
2007-07-19 |
Astrazeneca Ab |
Morpholino pyrimidine derivatives and their use in therapy
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
WO2007120897A2
(en)
*
|
2006-04-13 |
2007-10-25 |
The Trustees Of Columbia University In The City Of New York |
Compositions and intraluminal devices for inhibiting vascular stenosis
|
|
AR064571A1
(es)
|
2006-12-28 |
2009-04-08 |
Basf Ag |
Pirimidinas sustituidas en posicion 2 por heterociclos nitrogenados, medicamentos y composiciones farmaceuticas que las contienen y usos de las mismas en el tratamiento del cancer.
|
|
US8173647B2
(en)
|
2007-02-06 |
2012-05-08 |
Gordana Atallah |
PI 3-kinase inhibitors and methods of their use
|
|
US7957951B2
(en)
|
2007-03-16 |
2011-06-07 |
Robert Bosch Gmbh |
Address translation system for use in a simulation environment
|
|
AU2008273889B2
(en)
|
2007-07-09 |
2012-03-08 |
Astrazeneca Ab |
Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
|
|
WO2009066084A1
(en)
|
2007-11-21 |
2009-05-28 |
F. Hoffmann-La Roche Ag |
2 -morpholinopyrimidines and their use as pi3 kinase inhibitors
|
|
PT2259800E
(pt)
|
2008-03-05 |
2014-08-06 |
Novartis Ag |
Utililização de 5-(2,6-di-morfolin-4-il-pirimidin-4-il)-4- trifluorometil-piridin-2-ilamina para o tratamento de carcinoma pulmonar de não pequenas células com resistência adquirida aos moduladores do receptor de factor de crescimento epidérmico (egfr)
|
|
CN101980708B
(zh)
|
2008-03-26 |
2013-03-13 |
诺瓦提斯公司 |
作为vegf驱动的血管生成过程的有效调节剂的咪唑并喹啉类及嘧啶衍生物
|
|
EP2276750A2
(en)
|
2008-03-27 |
2011-01-26 |
Auckland Uniservices Limited |
Substituted pyrimidines and triazines and their use in cancer therapy
|
|
US8575338B2
(en)
|
2008-04-09 |
2013-11-05 |
Mitsubishi Tanabe Pharma Corporation |
Pyrimidine, pyridine and triazine derivatives as maxi-K channel openers
|
|
GB0815369D0
(en)
|
2008-08-22 |
2008-10-01 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
|
CN105030784A
(zh)
|
2008-10-31 |
2015-11-11 |
诺华股份有限公司 |
磷脂酰肌醇-3-激酶(PI3K)抑制剂和mTOR抑制剂的组合产品
|
|
GB2465405A
(en)
|
2008-11-10 |
2010-05-19 |
Univ Basel |
Triazine, pyrimidine and pyridine analogues and their use in therapy
|
|
WO2010068863A2
(en)
|
2008-12-12 |
2010-06-17 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimidine compounds and methods of making and using same
|
|
AU2010211672B2
(en)
|
2009-02-06 |
2016-08-04 |
Nippon Shinyaku Co., Ltd. |
Aminopyrazine derivative and medicine
|
|
JP5747440B2
(ja)
|
2009-02-06 |
2015-07-15 |
住友化学株式会社 |
ヒドラジド化合物及びその有害生物防除用途
|
|
ES2740424T3
(es)
|
2009-03-13 |
2020-02-05 |
Agios Pharmaceuticals Inc |
Métodos y composiciones para trastornos relacionados con la proliferación celular
|
|
WO2010120994A2
(en)
|
2009-04-17 |
2010-10-21 |
Wyeth Llc |
Ureidoaryl-and carbamoylaryl-morpholino- pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesis
|
|
ES2417355T3
(es)
|
2009-05-19 |
2013-08-07 |
Dow Agrosciences Llc |
Compuestos y métodos para el control de hongos
|
|
TW201105662A
(en)
|
2009-07-07 |
2011-02-16 |
Pathway Therapeutics Ltd |
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
|
|
AR077695A1
(es)
|
2009-08-04 |
2011-09-14 |
Schering Corp |
Derivados de pirimidina como inhibidores del factor ixa
|
|
AR077999A1
(es)
|
2009-09-02 |
2011-10-05 |
Vifor Int Ag |
Antagonistas de pirimidin y triazin-hepcidina
|
|
PH12012500491A1
(en)
|
2009-09-09 |
2018-03-21 |
Celgene Avilomics Res Inc |
P13 kinase inhibitors and uses thereof
|
|
JP5967827B2
(ja)
|
2009-12-09 |
2016-08-10 |
アジオス ファーマシューティカルズ， インコーポレイテッド |
Ｉｄｈ変異体をもつことを特徴とする癌治療用の治療的活性化合物
|
|
GB201004200D0
(en)
|
2010-03-15 |
2010-04-28 |
Univ Basel |
Spirocyclic compounds and their use as therapeutic agents and diagnostic probes
|
|
US9133123B2
(en)
|
2010-04-23 |
2015-09-15 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
US20130109643A1
(en)
|
2010-05-10 |
2013-05-02 |
The Johns Hopkins University |
Metabolic inhibitor against tumors having an idh mutation
|
|
CA2805669C
(en)
|
2010-07-16 |
2018-08-21 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
|
KR20130119928A
(ko)
|
2010-10-01 |
2013-11-01 |
노파르티스 아게 |
피리미딘 유도체의 제조 방법
|
|
CN107011359A
(zh)
|
2010-10-18 |
2017-08-04 |
塞伦尼斯医疗控股有限公司 |
可用于胆固醇动员的化合物、组合物和方法
|
|
GB201106829D0
(en)
|
2011-04-21 |
2011-06-01 |
Proximagen Ltd |
Heterocyclic compounds
|
|
CA2826387A1
(en)
|
2011-02-11 |
2012-08-16 |
Dana Farber Cancer Institute, Inc. |
Method of inhibiting hamartoma tumor cells
|
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
WO2013030368A1
(en)
|
2011-09-01 |
2013-03-07 |
Novartis Ag |
Pi3k inhibitor for use in the treatment of bone cancer or for preventing metastatic dissemination primary cancer cells into the bone
|
|
KR20140069235A
(ko)
|
2011-09-27 |
2014-06-09 |
노파르티스 아게 |
돌연변이체 idh의 억제제로서의 3-피리미딘-4-일-옥사졸리딘-2-온
|
|
JP2014528446A
(ja)
|
2011-10-06 |
2014-10-27 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
１，３−置換アゼチジンｐｄｅ１０阻害剤
|
|
UY34632A
(es)
|
2012-02-24 |
2013-05-31 |
Novartis Ag |
Compuestos de oxazolidin- 2- ona y usos de los mismos
|
|
WO2013173283A1
(en)
*
|
2012-05-16 |
2013-11-21 |
Novartis Ag |
Dosage regimen for a pi-3 kinase inhibitor
|
|
MX2014014969A
(es)
|
2012-06-06 |
2015-03-13 |
Novartis Ag |
Combinacion de un inhibidor de la 17-alfa-hidroxilasa (c17,20-liasa) y un inhibidor especifico de la pi-3k para tratar una enfermedad tumoral.
|
|
RU2705095C2
(ru)
|
2012-08-16 |
2019-11-05 |
Новартис Аг |
Комбинация ингибитора pik3 и ингибитора с-мет
|
|
MX360703B
(es)
|
2012-10-23 |
2018-11-14 |
Novartis Ag |
Proceso mejorado para la elaboración de 5-(2, 6-di-4-morfolinil-4-pirimidinil)-4-trifluoro-metil-piridin-2-amin a.
|
|
US9296733B2
(en)
|
2012-11-12 |
2016-03-29 |
Novartis Ag |
Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
|
|
CN105209460A
(zh)
|
2013-03-14 |
2015-12-30 |
诺华股份有限公司 |
作为突变idh抑制剂的3-嘧啶-4-基-噁唑烷-2-酮化合物
|
|
US9434719B2
(en)
|
2013-03-14 |
2016-09-06 |
Novartis Ag |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
|
|
CN103483345B
(zh)
|
2013-09-25 |
2016-07-06 |
中山大学 |
Pi3k激酶抑制剂、包含其的药物组合物及其应用
|
|
CN103694218B
(zh)
|
2013-12-05 |
2016-04-27 |
中山大学 |
嘧啶化合物、pi3k抑制剂、包含pi3k抑制剂的药物组合物及应用
|